Arv
latest news & developments
HIV responses succeed when we let communities lead
The Nomakhayas of Nqileni in the Eastern Cape give us a case study to replicate This content is restricted to registered users and subscribers. Get Your Free Account The Mail &…
How a change in ARV distribution could help treat more people with HIV
Private pharmacies to join the management of antiretroviral treatment programme, making it easier for those who need the life-long medicine
Mia Malan: Eight lessons the Covid pandemic taught me about journalism
During a crisis such as the Covid pandemic, people have simple demands of the media: how to protect themselves, which government rules they have to follow and what the future holds
Learning to find peace on the stage
artInsideOut launched an intensive three-week theatre course aimed at helping children use creativity to handle setbacks.
Universities offer HIV treatment
On-campus clinics roll out ARTs to students to improve access and decrease stigma
#AIDS2016: How a rural community helps each other stay on HIV treatment
An adherence club helped almost all patients stay on their treatment.
#AIDS2016: SA pays its HIV bill but faces budget gap for expanded treatment
Research predicts a substantial shortfall in HIV funding in the next five years as the country looks to put millions more people on treatment.
First ARVs from state-owned pharmaceutical company expected by 2017
As the world’s biggest consumer of ARVs, South Africa spends billions of rands purchasing the drugs on the international market every year.
From critical condition to stable
The nation’s healthcare system reflects the actions of the ministers responsible for it over the years.
ARV-shortages uncovered: Bhekisisa director speaks on VoW FM
Bhekisisa director Mia Malan speaks on The Science Inside show about ARV shortages on Voice of Wits radio station.
New HIV infections in SA fall by a third since 2004
Between 2004 and 2012, the number of new HIV infections have decreased from an estimated 540 000 to 370 000, shows a UNAids report.
Drug row sparked by HIV spending
A new study to be conducted in South Africa, Uganda and India has sparked a heated debate in the HIV activist and research community.
ARV plan bounces back
The hunt is on for a new private sector partner with the expertise to set up a drug-making plan.
Comment: Ignorant reporting can be lethal
As the fallout regarding misinformation about vaccines and antiretrovirals shows, words can kill.
State consolidates HIV treatment
New medicine combines ARVs into one pill, making them easier to supply.